How has been the historical performance of Hind.Organ.Chem.?

Answer:The historical performance of Hind.Organ.Chem. shows significant fluctuations in key financial metrics over the years, culminating in a notable recovery in the latest fiscal year.

Breakdown:
Hind.Organ.Chem. reported net sales of 535.87 Cr for the year ending March 2025, a decrease from 703.89 Cr in March 2024 and 631.44 Cr in March 2023. The total operating income mirrored this trend, falling to 535.87 Cr from 703.89 Cr in the previous year. The company's total expenditure, excluding depreciation, was 622.00 Cr, down from 704.88 Cr in March 2024. This resulted in an operating profit (PBDIT) of -63.38 Cr for March 2025, a stark contrast to the positive 15.70 Cr recorded in March 2024. However, the company achieved a profit before tax of 394.87 Cr in March 2025, recovering from a loss of -55.32 Cr in the prior year. Consequently, the profit after tax surged to 391.54 Cr, compared to a loss of -55.32 Cr in March 2024. The earnings per share (EPS) improved significantly to 58.24 from -8.12, indicating a strong turnaround. On the balance sheet, total assets slightly decreased to 1,564.37 Cr from 1,572.34 Cr, while total liabilities also decreased to 1,564.37 Cr from 1,572.34 Cr. The company’s cash flow from operating activities showed a positive trend, reaching 631.00 Cr in March 2025, compared to -65.00 Cr in March 2024, reflecting improved operational efficiency. Overall, while Hind.Organ.Chem. faced challenges in sales and operating profit, it demonstrated a remarkable recovery in profitability and cash flow in the latest fiscal year.